The dose is escalated over approximately 16 weeks following a protocol similar to Wegovy's escalation schedule
Instead, the FDA cited 'deficiencies in the manufacturing and chemistry documentation (CMC).' This means the issues are related to the paperwork and processes around how the drug is made, rather than how well it works or its side effects in patients
For pharmaceutical leaders, the strategic implications are significant
Camilleri said that constipation may be one clue that people will have trouble with gastroparesis on a GLP-1 medication but that there are still many questions to answer
They are not approved for human or veterinary consumption and must not be used to diagnose, treat, cure, or prevent any disease
Why GLP-1 Medications Are So Expensive The price of GLP-1 medications reflects several factors related to pharmaceutical development and manufacturing